Potential routes through which the MD may benefit women with IR due to T2DM and/or PCOS encompass reducing inflammatory and oxidative stress markers and enhancing the lipid profile, insulin sensitivity, endothelial function, as well as fostering anti-atherosclerotic and anti-thrombotic properties (93). This evidence concerns the gene INS and polycystic ovary syndrome.